Compounds > cirsimaritin
Page last updated: 2024-09-05

cirsimaritin and alogliptin

cirsimaritin has been researched along with alogliptin in 1 studies

Compound Research Comparison

Studies
(cirsimaritin)		Trials
(cirsimaritin)		Recent Studies (post-2010)
(cirsimaritin)		Studies
(alogliptin)		Trials
(alogliptin)		Recent Studies (post-2010) (alogliptin)
4902130280261

Protein Interaction Comparison

ProteinTaxonomycirsimaritin (IC50)alogliptin (IC50)
Cytochrome P450 1A2Homo sapiens (human)10
Cytochrome P450 3A4Homo sapiens (human)10
Cytochrome P450 2D6Homo sapiens (human)10
Cytochrome P450 2C9 Homo sapiens (human)10
Dipeptidyl peptidase 4Homo sapiens (human)0.0066
Cytochrome P450 2C19Homo sapiens (human)10
Dipeptidyl peptidase 8Homo sapiens (human)0.01

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ1

Reviews

1 review(s) available for cirsimaritin and alogliptin

ArticleYear
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship

2018